User profiles for Veer Sangha

Veer Sangha

Yale University
Verified email at yale.edu
Cited by 138

[HTML][HTML] Automated multilabel diagnosis on electrocardiographic images and signals

V Sangha, BJ Mortazavi, AD Haimovich… - Nature …, 2022 - nature.com
The application of artificial intelligence (AI) for automated diagnosis of electrocardiograms (ECGs)
can improve care in remote settings but is limited by the reliance on infrequently …

Patterns of prescribing sodium-glucose cotransporter-2 inhibitors for Medicare beneficiaries in the United States

V Sangha, K Lipska, Z Lin, SE Inzucchi… - … Quality and Outcomes, 2021 - Am Heart Assoc
Background: Evidence from large randomized clinical trials supports the benefit of SGLT2i (sodium-glucose
cotransporter-2 inhibitors) to improve cardiovascular and kidney outcomes …

[HTML][HTML] Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices

A Khunte, V Sangha, EK Oikonomou, LS Dhingra… - npj Digital …, 2023 - nature.com
Artificial intelligence (AI) can detect left ventricular systolic dysfunction (LVSD) from
electrocardiograms (ECGs). Wearable devices could allow for broad AI-based screening but …

[HTML][HTML] A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations

R Khera, BJ Mortazavi, V Sangha, F Warner… - npj Digital …, 2022 - nature.com
Diagnosis codes are used to study SARS-CoV2 infections and COVID-19 hospitalizations in
administrative and electronic health record (EHR) data. Using EHR data (April 2020–March …

Detection of left ventricular systolic dysfunction from electrocardiographic images

V Sangha, AA Nargesi, LS Dhingra, A Khunte… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Left ventricular (LV) systolic dysfunction is associated with a >8-fold
increased risk of heart failure and a 2-fold risk of premature death. The use of ECG signals in …

[HTML][HTML] County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries

J Hanna, AA Nargesi, UR Essien, V Sangha… - American Journal of …, 2022 - Elsevier
Background Cardioprotective antihyperglycemic agents, SGLT2 inhibitors (SGLT2i) and
GLP-1 receptor agonists (GLP1RA), improve outcomes of patients with type 2 diabetes, but …

[HTML][HTML] Identification of Hypertrophic Cardiomyopathy on Electrocardiographic Images with Deep Learning

V Sangha, LS Dhingra, E Oikonomou, A Aminorroaya… - medRxiv, 2023 - ncbi.nlm.nih.gov
Background: Hypertrophic cardiomyopathy (HCM) affects 1 in every 200 individuals and is
the leading cause of sudden cardiac death in young adults. HCM can be identified using an …

[HTML][HTML] Accuracy of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations from the electronic health record

R Khera, BJ Mortazavi, V Sangha, F Warner, HP Young… - medRxiv, 2021 - ncbi.nlm.nih.gov
Objective: Real-world data have been critical for rapid-knowledge generation throughout the
COVID-19 pandemic. To ensure high-quality results are delivered to guide clinical decision …

Biometric contrastive learning for data-efficient deep learning from electrocardiographic images

V Sangha, A Khunte, G Holste… - Journal of the …, 2024 - academic.oup.com
Objective Artificial intelligence (AI) detects heart disease from images of electrocardiograms
(ECGs). However, traditional supervised learning is limited by the need for large amounts of …

Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for wearable devices

A Khunte, V Sangha, EK Oikonomou, LS Dhingra… - medRxiv, 2022 - medrxiv.org
Artificial intelligence (AI) can detect left ventricular systolic dysfunction (LVSD) from
electrocardiograms (ECGs). Wearable devices could allow for broad AI-based screening but …